MMED
MiniMed Group, Inc. Common Stock NASDAQ Listed Mar 5, 2026$22.40
+1.77%
vs $22.01
Mkt Cap $6.3B
52w Low $10.80
89.0% of range
52w High $23.84
50d MA $19.22
200d MA $15.95
P/E (TTM)
-12.6x
EV/EBITDA
44.2x
P/B
1.9x
Debt/Equity
0.0x
ROE
—
P/FCF
-118.7x
RSI (14)
71.30
ATR (14)
$1.16
Beta
0.00
50d MA
$19.22
200d MA
$15.95
Avg Volume
1.9M
MiniMed Group, Inc. engages in the development, manufacturing, and marketing of a wide range of medical devices and solutions for diabetes management. Its offerings include insulin pumps, continuous glucose monitoring systems, infusion sets, software platforms, and related accessories that help patients and healthcare providers effectively monitor and control blood glucose levels. The company was founded by Alfred E. Mann in 1983 and is headquartered in Northridge, CA.
18000 Devonshire Street · Northridge, CA 91325 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 1, 2026 | BMO | 0.12 | 0.10 | -19.4% | 20.26 | +0.7% | +10.7% | +6.0% | +0.3% | -2.3% | +0.1% | — |
| Jun 3, 2026 | BMO | -0.15 | -0.68 | -356.1% | 14.26 | +0.0% | -1.4% | +1.2% | +4.6% | +1.6% | -2.7% | — |
| Apr 17, 2026 | BMO | 0.17 | -0.16 | -194.0% | 14.44 | -0.6% | -4.4% | -4.4% | -0.1% | +3.3% | -3.2% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 28 | UBS | Initiates | Buy | $25 | $17.67 | $17.91 | +1.4% | -0.2% | +4.3% | -1.4% | -0.6% | +5.8% |
| May 12 | The Benchmark Company | Initiates | Buy | $20 | $11.16 | $11.31 | +1.3% | +6.5% | -6.0% | -0.9% | -2.5% | +0.7% |
No insider trades available.
S-4
!!! Very High
MiniMed Group, Inc. -- Merger Registration
Sep 14
8-K · 2.02
!! High
MiniMed Group, Inc. -- 8-K 2.02: Earnings Results
Sep 1
8-K · 8.01
!! High
MiniMed Group, Inc. -- 8-K 8.01: Material Event / Announcement
Jun 29
8-K · 2.02
!! High
MiniMed Group, Inc. -- 8-K 2.02: Earnings Results
MiniMed Group reported Q4 and full-year fiscal 2026 financial results, providing investors with updated performance metrics for the company's operations.
Jun 3
8-K
MiniMed Group, Inc. -- 8-K Filing
Medtronic appointed a seasoned executive from Danaher with extensive regulatory and quality expertise to lead its Engineering and Innovation Center, strengthening the company's product development capabilities.
May 18
8-K · 7.01
! Medium
MiniMed Group, Inc. -- 8-K 7.01: Regulation FD Disclosure
Medtronic disclosed an unauthorized third-party breach of its IT systems; the company activated incident response protocols and engaged external cybersecurity experts to investigate and remediate the security breach.
Apr 27
8-K · 5.02
!!! Very High
Unknown — 8-K 5.02: Executive Change
I cannot provide a meaningful analysis of this filing because the summary provided is incomplete and contains only procedural language referencing exhibits rather than details about the actual executive change, compensation, or departure rationale.
Mar 27
8-K · 7.01
! Medium
Unknown — 8-K 7.01: Regulation FD Disclosure
MindMed's incomplete FD disclosure regarding future period results raises concerns about management's confidence in guidance and potential operational challenges, warranting cautious investor attention.
Mar 25
8-K · 7.01
! Medium
Unknown — 8-K 7.01: Regulation FD Disclosure
Medtronic will face $0.04 per-share dilution in Q4 FY2026 from its MiniMed IPO, creating near-term EPS headwinds that investors should factor into earnings estimates.
Mar 24
8-K · 5.02
!!! Very High
MiniMed Group, Inc. -- 8-K 5.02: Executive Change
Brian Sandstrom's resignation as director of MiniMed Group signals potential leadership transitions that investors should monitor for impact on board oversight and strategic direction.
Mar 9
Institutional (13F) — Top 20
All ↗
| # | Manager | Shares | Value | Chg | Period |
|---|---|---|---|---|---|
| 1 | Massachusetts Financial Services Co /ma/ | 8,334,738 | $125M | New | Jun 2026 |
| 2 | Citadel Advisors Llc | 5,731,406 | $86M | — | Jun 2026 |
| 3 | Longaeva Partners L.p. | 3,178,654 | $47M | New | Mar 2026 |
| 4 | Millennium Management Llc | 3,060,615 | $46M | Added | Jun 2026 |
| 5 | Blackrock, Inc. | 1,996,489 | $30M | New | Jun 2026 |
| 6 | Alyeska Investment Group, L.p. | 2,000,000 | $30M | New | Mar 2026 |
| 7 | Norges Bank | 1,961,002 | $29M | New | Jun 2026 |
| 8 | Hood River Capital Management Llc | 1,505,778 | $22M | New | Mar 2026 |
| 9 | Fmr Llc | 1,365,000 | $20M | New | Mar 2026 |
| 10 | Boston Partners | 902,359 | $13M | Added | Jun 2026 |
| 11 | Healthcare Of Ontario Pension Plan Trust Fund | 750,000 | $11M | New | Mar 2026 |
| 12 | Nuveen, Llc | 539,313 | $8M | New | Jun 2026 |
| 13 | Exoduspoint Capital Management, Lp | 409,248 | $6M | New | Mar 2026 |
| 14 | Vanguard Capital Management Llc | 323,325 | $5M | New | Jun 2026 |
| 15 | Ubs Group Ag | 311,349 | $5M | New | Mar 2026 |
| 16 | Tudor Investment Corp Et Al | 258,215 | $4M | Added | Jun 2026 |
| 17 | Vanguard Portfolio Management Llc | 193,047 | $3M | New | Jun 2026 |
| 18 | Hrt Financial Lp | 165,054 | $2M | New | Mar 2026 |
| 19 | First Trust Advisors Lp | 99,149 | $1M | New | Mar 2026 |
| 20 | Renaissance Technologies Llc | 88,300 | $1M | New | Jun 2026 |
Mutual Funds / ETFs (N-PORT) — Top 19
All ↗
Valuation
Market Cap
$6.29B
Enterprise Value
$6.28B
P/E (TTM)
-12.58x
Forward P/E
40.73x
PEG Ratio
-0.17x
P/B
1.89x
P/S
1.90x
P/FCF
-118.68x
EV/EBITDA
44.22x
Shares Out
280.8M
Financials (TTM)
Revenue
$3.31B
Net Income
-$485.0M
EBITDA
$142.0M
Free Cash Flow
-$53.0M
Op Cash Flow
$140.0M
EPS Basic
$-0.89
EPS Diluted
$-1.78
EPS Forward
$0.55
Gross Margin
54.0%
Op Margin
3.3%
Net Margin
-14.7%
Balance Sheet
Total Assets
$4.20B
Total Liab.
$870.0M
Total Equity
$3.33B
Cash
$11.0M
LT Debt
$0
Book Value/Sh
$11.86
Debt/Equity
0.00x
Current Ratio
1.32
Quick Ratio
0.89
Returns & Growth
ROE
—
ROA
—
ROIC
-5.8%
Rev Growth YoY
+10.0%
EPS Growth YoY
-122.5%
Price Returns
2W
+8.6%
1M
+9.2%
3M
+49.7%
6M
+37.9%
12M
+19.0%
Technicals
52W High
$23.84
52W Low
$10.80
50d MA
$19.22
200d MA
$15.95
RSI (14)
71.30
ATR (14)
$1.16
Beta
0.00
Avg Volume
1.9M
Dividends
Div Rate
$0.00
Div Yield
—
Frequency
—
Ex-Div Date
—
Analyst Price Targets
Consensus
—
High
—
Low
—
Median
—
Data updated apr 26, 2026 12:40pm
· Source: financialmodelingprep.com